One in Three Adults Turn to Cannabis for Sleep
Published in Cannabis Daily
Cannabis for Sleep: Why Millions Are Choosing It Over Traditional Sleep Medications Sleep has become one of the most significant health challenges facing modern society. According to multiple surveys, roughly one in three adults turn to cannabis to sleep – falling asleep, staying asleep, or improve overall sleep quality. As sleep disorders continue to rise, many consumers are exploring alternatives to traditional sleep medications, creating a growing market for cannabis-based sleep solutions.
The Fresh Toast – In a surprise, one in three adults turn to cannabis for sleep – sending people to bed while upending the sleep aid industry.
The popularity of cannabis as a sleep aid reflects a broader sleep crisis. Millions of Americans struggle with insomnia, restless sleep, sleep apnea, anxiety-related sleep disturbances, and chronic stress. Poor sleep is more than an inconvenience—it can have serious consequences for physical and mental health. Research has consistently linked inadequate sleep to increased risks of obesity, heart disease, diabetes, depression, anxiety, impaired immune function, and cognitive decline. Even a few nights of poor sleep can affect mood, decision-making, memory, and workplace performance. Long-term sleep deprivation has also been associated with increased mortality rates and a reduced quality of life.
For decades, people seeking better sleep primarily relied on mainstream sleep aids. These include prescription medications such as Ambien (zolpidem), Lunesta (eszopiclone), and benzodiazepines, as well as over-the-counter options like melatonin supplements and antihistamine-based products such as Unisom and Benadryl. While these treatments can be effective, many users report drawbacks. Prescription sleep medications may cause next-day grogginess, dependency concerns, memory issues, and unusual behaviors such as sleepwalking. Antihistamine-based sleep aids often leave users feeling sluggish the following morning and may become less effective with prolonged use. Even melatonin, generally considered safe, does not work for everyone and is most effective for specific sleep-related issues such as jet lag or circadian rhythm disruptions. Cannabis offers a different approach. Many consumers report products containing THC, CBD, or combinations of cannabinoids help reduce anxiety, quiet racing thoughts, and promote relaxation before bedtime. Some users say cannabis helps them fall asleep faster and experience fewer nighttime awakenings. Unlike traditional pharmaceuticals, cannabis products are available in a wide range of formats, including gummies, tinctures, capsules, beverages, and vape products. This variety allows consumers to tailor their sleep routine to their individual needs and preferences.
However, like most sleep aides, cannabis is not a perfect solution. Experts note heavy or long-term THC use may affect sleep architecture, particularly REM sleep, and some users may develop tolerance over time. Individual responses also vary significantly depending on dosage, cannabinoid profile, and personal physiology. The growing interest in cannabis for sleep reflects a larger shift in consumer behavior. Many people are increasingly seeking natural or plant-based wellness options and are looking for alternatives to prescription medications. As cannabis legalization expands and research continues, sleep remains one of the most commonly cited reasons people incorporate cannabis into their wellness routines.
Ultimately, whether someone chooses cannabis, melatonin, prescription medication, or lifestyle interventions such as improved sleep hygiene, the goal remains the same: achieving restorative, consistent sleep. Given the profound impact sleep has on nearly every aspect of health, finding an effective solution may be one of the most important investments a person can make in their long-term well-being.
The Fresh Toast is a daily lifestyle platform with a side of cannabis. For more information, visit www.thefreshtoast.com.
























Comments